Development and testing of an endometrial status assessment test based on RNAampliSeq technology

Abstract

BACKGROUND: Approximately two thirds of all implantation failures are due to impaired endometrial receptivity. The lack of implantation may be due to an implantation window failure found in approximately 25-30% of women with a history of failure to perform assisted reproductive technology protocols. The receptivity phase in such patients can be shifted in terms of timing, have a short duration, or not form. Currently, there are several commercial tests for determining endometrial receptivity based on transcriptomic data. However, these tests differ very significantly from each other in the set of genes studied, and the exact mechanism of endometrial receptivity is still not fully understood.

AIM: The aim of this study was to create and check our own test based on RNA AmpliSeq technology to assess the receptivity status of the endometrium and the implantation window.

MATERIALS AND METHODS: We previously created an RNAampliSeq panel containing 421 gens. With its use, the differential expression of these genes was analyzed in 38 endometrial samples taken in the proliferative and receptive phases.

RESULTS: The studied samples form clearly distinguishable clusters with the receptive and proliferative endometria. 271 genes from our panel are differentially expressed in different phases of the menstrual cycle.

CONCLUSIONS: We have created and tested a model that allows clearly distinguishing between the proliferative endometrium and the receptive one and identifying patients with disorders of the menstrual cycle.

Keywords

endometrium / receptivity / test / RNAampliSeq

References

[1] Achache H, Revel A. Endometrial receptivity markers, the journey to successful embryo implantation. Hum Reprod Update. 2006;12(6):731–746. DOI: 10.1093/humupd/dml004

[2] Achache H., Revel A. Endometrial receptivity markers, the journey to successful embryo implantation // Hum. Reprod. Update. 2006. Vol. 12. No. 6. P. 731–746. DOI: 10.1093/humupd/dml004

[3] Haouzi D, Dechaud H, Assou S, et al. Insights into human endometrial receptivity from transcriptomic and proteomic data. Reprod Biomed Online. 2012;24(1):23–34. DOI: 10.1016/j.rbmo.2011.09.009

[4] Haouzi D., Dechaud H., Assou S., et al. Insights into human endometrial receptivity from transcriptomic and proteomic data // Reprod. Biomed Online. 2012. Vol. 24. No. 1. P. 23–34. DOI: 10.1016/j.rbmo.2011.09.009

[5] Lessey BA, Young SL. What exactly is endometrial receptivity? Fertil Steril. 2019;111(4):611–617. DOI: 10.1016/j.fertnstert.2019.02.009

[6] Lessey B.A., Young S.L. What exactly is endometrial receptivity? // Fertil. Steril. 2019. Vol. 111. No. 4. P. 611–617. DOI: 10.1016/j.fertnstert.2019.02.009

[7] Bai X, Zheng L, Li D, et al. Research progress of endometrial receptivity in patients with polycystic ovary syndrome: a systematic review. Reprod Biol Endocrinol. 2021;19(1):122. DOI: 10.1186/s12958-021-00802-4

[8] Bai X., Zheng L., Li D., et al. Research progress of endometrial receptivity in patients with polycystic ovary syndrome: a systematic review // Reprod. Biol. Endocrinol. 2021. Vol. 19. No. 1. P. 122. DOI: 10.1186/s12958-021-00802-4

[9] Enciso M, Aizpurua J, Rodríguez-Estrada B, et al. The precise determination of the window of implantation significantly improves ART outcomes. Sci Rep. 2021;11(1):13420. DOI: 10.1038/s41598-021-92955-w

[10] Enciso M., Aizpurua J., Rodríguez-Estrada B., et al. The precise determination of the window of implantation significantly improves ART outcomes // Sci. Rep. 2021. Vol. 11. No. 1. P. 3420. DOI: 10.1038/s41598-021-92955-w

[11] Díaz-Gimeno P, Horcajadas JA, Martínez-Conejero JA, et al. A genomic diagnostic tool for human endometrial receptivity based on the transcriptomic sDiazignature. Fertil Steril. 2011;95(1):50–60. DOI: 10.1016/j.fertnstert.2010.04.063

[12] Díaz-Gimeno P., Horcajadas J.A., Martínez-Conejero J.A., et al. A genomic diagnostic tool for human endometrial receptivity based on the transcriptomic sDiazignature // Fertil. Steril. 2011. Vol. 95. No. 1. P. 50–60. DOI: 10.1016/j.fertnstert.2010.04.063

[13] Ruiz-Alonso M, Blesa D, Simón C. The genomics of the human endometrium. Biochim Biophys Acta. 2012;1822(12):1931–1942. DOI: 10.1016/j.bbadis.2012.05.004

[14] Ruiz-Alonso M., Blesa D., Simón C. The genomics of the human endometrium // Biochim. Biophys. Acta. 2012. Vol. 1822. No. 12. P. 1931–1942. DOI: 10.1016/j.bbadis.2012.05.004

[15] Ruiz-Alonso M, Blesa D, Díaz-Gimeno P, et al. The endometrial receptivity array for diagnosis and personalized embryo transfer as a treatment for patients with repeated implantation failure. Fertil Steril. 2013;100(3):818–824. DOI: 10.1016/j.fertnstert.2013.05.004

[16] Ruiz-Alonso M., Blesa D., Díaz-Gimeno P., et al. The endometrial receptivity array for diagnosis and personalized embryo transfer as a treatment for patients with repeated implantation failure // Fertil. Steril. 2013. Vol. 100. No. 3. P. 818–824. DOI: 10.1016/j.fertnstert.2013.05.004

[17] Kibanov MV, Makhmudova GM, Gokhberg YA. In search for an ideal marker of endometrial receptivity: from histology to comprehensive molecular genetics-based approaches. Almanac of Clinical Medicine. 2019;47(1):12–25. DOI: 10.18786/2072-0505-2019-47-005

[18] Кибанов М.В., Махмудова Г.М., Гохберг Я.А. Поиск идеального маркера для оценки рецептивности эндометрия: от гистологии до современных молекулярно-генетических подходов // Альманах клинической медицины. 2019. Т. 47. № 1. C. 12–25. DOI: 10.18786/2072-0505-2019-47-005

[19] Coutifaris C, Myers ER, Guzick DS, et al.; NICHD National Cooperative Reproductive Medicine Network. Histological dating of timed endometrial biopsy tissue is not related to fertility status. Fertil Steril. 2004;82(5):1264–1272. DOI: 10.1016/j.fertnstert.2004.03.069

[20] Coutifaris C., Myers E.R., Guzick D.S., et al; NICHD National Cooperative Reproductive Medicine Network. Histological dating of timed endometrial biopsy tissue is not related to fertility status // Fertil. Steril. 2004. Vol. 82. No. 5. P. 1264–1272. DOI: 10.1016/j.fertnstert.2004.03.069

[21] Murray MJ, Meyer WR, Zaino RJ, et al. A critical analysis of the accuracy, reproducibility, and clinical utility of histologic endometrial dating in fertile women. Fertil Steril. 2004;81(5):1333–1343. DOI: 10.1016/j.fertnstert.2003.11.030

[22] Murray M.J., Meyer W.R., Zaino R.J., et al. A critical analysis of the accuracy, reproducibility, and clinical utility of histologic endometrial dating in fertile women // Fertil. Steril. 2004. Vol. 81. No. 5. P. 1333–1343. DOI: 10.1016/j.fertnstert.2003.11.030

[23] Ruiz-Alonso M, Valbuena D, Gomez C, et al. Endometrial Receptivity Analysis (ERA): data versus opinions. Hum Reprod Open. 2021;2021(2). DOI: 10.1093/hropen/hoab011

[24] Ruiz-Alonso M., Valbuena D., Gomez C., et al. Endometrial Receptivity Analysis (ERA): data versus opinions // Hum. Reprod. Open. 2021. Vol. 2021. No. 2. DOI: 10.1093/hropen/hoab011

[25] Altmäe S, Koel M, Võsa U, et al. Meta-signature of human endometrial receptivity: a meta-analysis and validation study of transcriptomic biomarkers. Sci Rep. 2017;7(1). DOI: 10.1038/s41598-017-10098-3

[26] Altmäe S., Koel M., Võsa U., et al. Meta-signature of human endometrial receptivity: a meta-analysis and validation study of transcriptomic biomarkers // Sci. Rep. 2017. Vol. 7. No. 1. P. 10077. DOI: 10.1038/s41598-017-10098-3

[27] Haouzi D, Entezami F, Torre A, et al. Customized frozen embryo transfer after identification of the receptivity window with a transcriptomic approach improves the implantation and live birth rates in patients with repeated implantation failure. Reprod Sci. 2021;28(1):69–78. DOI: 10.1007/s43032-020-00252-0

[28] Haouzi D., Entezami F., Torre A., et al. Customized frozen embryo transfer after identification of the receptivity window with a transcriptomic approach improves the implantation and live birth rates in patients with repeated implantation failure // Reprod. Sci. 2021. Vol. 28. No. 1. P. 69–78. DOI: 10.1007/s43032-020-00252-0

[29] Gómez E, Ruíz-Alonso M, Miravet J, et al. Human endometrial transcriptomics: implications for embryonic implantation. Cold Spring Harb Perspect Med. 2015;5(7). DOI: 10.1101/cshperspect.a022996

[30] Gómez E., Ruíz-Alonso M., Miravet J., et al. Human endometrial transcriptomics: implications for embryonic implantation // Cold Spring Harb. Perspect. Med. 2015. Vol. 5. No. 7. DOI: 10.1101/cshperspect.a022996

[31] Predeus AV, Vashukova ES, Glotov AS, et al. Next-generation sequencing of matched ectopic and eutopic endometrium identifies novel endometriosis-related genes. Russ J Genet. 2018;54(11): 1358–1365. DOI: 10.1134/S1022795418110133

[32] Predeus A.V., Vashukova E.S., Glotov A.S., et al. Next-generation sequencing of matched ectopic and eutopic endometrium identifies novel endometriosis-related genes. Russ. J. Genet. 2018. Vol. 54. No. 11. P. 1358–1365. DOI: 10.1134/S1022795418110133

[33] Altmäe S, Esteban FJ, Stavreus-Evers A, et al. Guidelines for the design, analysis and interpretation of ‘omics’ data: focus on human endometrium. Hum Reprod Update. 2014;20(1):12–28. DOI: 10.1093/humupd/dmt048

[34] Altmäe S., Esteban F.J., Stavreus-Evers A., et al. Guidelines for the design, analysis and interpretation of ‘omics’ data: focus on human endometrium // Hum. Reprod. Update. 2014. Vol. 20. No. 1. P. 12–28. DOI: 10.1093/humupd/dmt048

[35] Horcajadas JA, Pellicer A, Simón C. Wide genomic analysis of human endometrial receptivity: new times. New opportunities. Hum Reprod Update. 2007;13(1):77–86. DOI: 10.1093/humupd/dml046

[36] Horcajadas J.A., Pellicer A., Simón C. Wide genomic analysis of human endometrial receptivity: new times. New opportunities // Hum. Reprod. Update. 2007. Vol. 13. No. 1. P. 77–86. DOI: 10.1093/humupd/dml046

[37] Zhang L, Liu X, Liu J, et al. The developmental transcriptome landscape of receptive endometrium during embryo implantation in dairy goats. Gene. 2017;633:82–95. DOI: 10.1016/j.gene.2017.08.026

[38] Zhang L., Liu X., Liu J., et al. The developmental transcriptome landscape of receptive endometrium during embryo implantation in dairy goats // Gene. 2017. Vol. 633. P. 82–95. DOI: 10.1016/j.gene.2017.08.026.

[39] Franasiak JM, Burns KA, Slayden O, et al. Endometrial CXCL13 expression is cycle regulated in humans and aberrantly expressed in humans and Rhesus macaques with endometriosis. Reprod Sci. 2015;22(4):442–451. DOI: 10.1177/1933719114542011

[40] Franasiak J.M., Burns K.A., Slayden O., et al. Endometrial CXCL13 expression is cycle regulated in humans and aberrantly expressed in humans and Rhesus macaques with endometriosis // Reprod. Sci. 2015. Vol. 22. No. 4. P. 442–451. DOI: 10.1177/1933719114542011

[41] Ohye H, Sugawara M. Dual oxidase, hydrogen peroxide and thyroid diseases. Exp Biol Med (Maywood). 2010;235(4):424–433. DOI: 10.1258/ebm.2009.009241

[42] Ohye H., Sugawara M. Dual oxidase, hydrogen peroxide and thyroid diseases // Exp. Biol. Med. (Maywood). 2010. Vol. 235. No. 4. P. 424–433. DOI: 10.1258/ebm.2009.009241

[43] Pathak BR, Breed AA, Apte S, et al. Cysteine-rich secretory protein 3 plays a role in prostate cancer cell invasion and affects expression of PSA and ANXA1. Mol Cell Biochem. 2016;411(1-2):11–21. DOI: 10.1007/s11010-015-2564-2

[44] Pathak B.R., Breed A.A., Apte S., et al. Cysteine-rich secretory protein 3 plays a role in prostate cancer cell invasion and affects expression of PSA and ANXA1 // Mol. Cell Biochem. 2016. Vol. 411. No. 1–2. P. 11–21. DOI: 10.1007/s11010-015-2564-2

[45] Su MT, Huang JY, Tsai HL, et al. A common variant of PROK1 (V67I) acts as a genetic modifier in early human pregnancy through down-regulation of gene expression. Int J Mol Sci. 2016;17(2):162. DOI: 10.3390/ijms17020162

[46] Su M.T., Huang J.Y., Tsai H.L., et al. A common variant of PROK1 (V67I) acts as a genetic modifier in early human pregnancy through down-regulation of gene expression // Int. J. Mol. Sci. 2016. Vol. 17. No. 2. P. 162. DOI: 10.3390/ijms17020162

[47] Macdonald LJ, Sales KJ, Grant V, et al. Prokineticin 1 induces Dickkopf 1 expression and regulates cell proliferation and decidualization in the human endometrium. Mol Hum Reprod. 2011;17(10):626–636. DOI: 10.1093/molehr/gar031

[48] Macdonald L.J., Sales K.J., Grant V., et al. Prokineticin 1 induces Dickkopf 1 expression and regulates cell proliferation and decidualization in the human endometrium // Mol. Hum. Reprod. 2011. Vol. 17. No. 10. P. 626–636. DOI: 10.1093/molehr/gar031

[49] Chen L, Xiao D, Tang F, et al. CAPN6 in disease: an emerging therapeutic target (review). Int J Mol Med. 2020;46(5):1644–1652. DOI: 10.3892/ijmm.2020.4734

[50] Chen L., Xiao D., Tang F., et al. CAPN6 in disease: an emerging therapeutic target (Review) // Int. J. Mol. Med. 2020. Vol. 46. No. 5. P. 1644–1652. DOI: 10.3892/ijmm.2020.4734

[51] Allegra A, Marino A, Coffaro F, et al. Is there a uniform basal endometrial gene expression profile during the implantation window in women who became pregnant in a subsequent ICSI cycle? Hum Reprod. 2009;24(10):2549–2257. DOI: 10.1093/humrep/dep222

[52] Allegra A., Marino A., Coffaro F. et al. Is there a uniform basal endometrial gene expression profile during the implantation window in women who became pregnant in a subsequent ICSI cycle? // Hum. Reprod. 2009. Vol. 24. No. 10. P. 2549–2257. DOI: 10.1093/humrep/dep222

[53] Talbi S, Hamilton AE, Vo KC, et al. Molecular phenotyping of human endometrium distinguishes menstrual cycle phases and underlying biological processes in normo-ovulatory women. Endocrinology. 2006;147(3):1097–1121. DOI: 10.1210/en.2005-1076

[54] Talbi S., Hamilton A.E., Vo K.C., et al. Molecular phenotyping of human endometrium distinguishes menstrual cycle phases and underlying biological processes in normo-ovulatory women // Endocrinology. 2006. Vol. 147. No. 3. P. 1097–1121. DOI: 10.1210/en.2005-1076

[55] Liu LJ, Liao JM, Zhu F. Proliferating cell nuclear antigen clamp associated factor, a potential proto-oncogene with increased expression in malignant gastrointestinal tumors. World J Gastrointest Oncol. 2021;13(10):1425–1439. DOI: 10.4251/wjgo.v13.i10.1425

[56] Liu L.J., Liao J.M., Zhu F. Proliferating cell nuclear antigen clamp associated factor, a potential proto-oncogene with increased expression in malignant gastrointestinal tumors // World J. Gastrointest. Oncol. 2021. Vol. 13. No. 10. P. 1425–1439. DOI: 10.4251/wjgo.v13.i10.1425

[57] Xu Z, Ye J, Bao P, et al. Long non-coding RNA SNHG3 promotes the progression of clear cell renal cell carcinoma via regulating BIRC5 expression. Transl Cancer Res. 2021;10(10):4502–4513. DOI: 10.21037/tcr-21-1802

[58] Xu Z., Ye J., Bao P., et al. Long non-coding RNA SNHG3 promotes the progression of clear cell renal cell carcinoma via regulating BIRC5 expression // Transl. Cancer. Res. 2021. Vol. 10. No. 10. P. 4502–4513. DOI: 10.21037/tcr-21-1802

[59] Jin Z, Peng F, Zhang C, et al. Expression, regulating mechanism and therapeutic target of KIF20A in multiple cancer. Heliyon. 2023;9(2). DOI: 10.1016/j.heliyon.2023.e13195

[60] Jin Z., Peng F., Zhang C., et al. Expression, regulating mechanism and therapeutic target of KIF20A in multiple cancer // Heliyon. 2023. Vol. 9. No. 2. DOI: 10.1016/j.heliyon.2023.e13195

RIGHTS & PERMISSIONS

Eсо-Vector